{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:57:03Z","timestamp":1789131423970,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ajpath.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T05:48:56Z","timestamp":1614404936000},"page":"795-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Extracellular Vesicles and Renal Endothelial Cells"],"prefix":"10.1016","volume":"191","author":[{"given":"Elisa","family":"Varrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Carnicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-744X","authenticated-orcid":false,"given":"Maurizio","family":"Brigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2021.02.011_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/toxins12060373","article-title":"Valid presumption of Shiga toxin-mediated damage of developing erythrocytes in EHEC-associated hemolytic uremic syndrome","volume":"12","author":"Detzner","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib2","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2021.02.011_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EHEC-0007-2013","article-title":"The locus of enterocyte effacement and associated virulence factors of enterohemorrhagic Escherichia coli","volume":"2","author":"Stevens","year":"2014","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ajpath.2021.02.011_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1160\/TH05-04-0265","article-title":"Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium","volume":"94","author":"Bielaszewska","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2021.02.011_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0046-8177(88)80093-5","article-title":"The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections","volume":"19","author":"Richardson","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib6","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.4049\/jimmunol.1402470","article-title":"Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome","volume":"194","author":"Arvidsson","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/toxins12050345","article-title":"Molecular biology of Escherichia coli Shiga toxins' effects on mammalian cells","volume":"12","author":"Menge","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib8","first-page":"e05967","article-title":"Pathogenicity assessment of Shiga toxin-producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC","volume":"18","author":"Koutsoumanis","year":"2020","journal-title":"EFSA J"},{"key":"10.1016\/j.ajpath.2021.02.011_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/338115","article-title":"Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms","volume":"185","author":"Friedrich","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2021.02.011_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JCM.44.2.313-317.2006","article-title":"Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome","volume":"44","author":"Brigotti","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0b013e3182074d22","article-title":"Clinical relevance of Shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome","volume":"30","author":"Brigotti","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajpath.2021.02.011_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/166.1.154","article-title":"Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy","volume":"166","author":"Caprioli","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2021.02.011_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2021.02.011_bib14","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1111\/apa.13211","article-title":"Serum Shiga toxin 2 values in patients during acute phase of diarrhoea-associated haemolytic uraemic syndrome","volume":"104","author":"He","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ajpath.2021.02.011_bib15","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.3390\/toxins7114564","article-title":"A rapid and sensitive method to measure the functional activity of Shiga toxins in human serum","volume":"7","author":"Arfilli","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib16","doi-asserted-by":"crossref","first-page":"e6990","DOI":"10.1371\/journal.pone.0006990","article-title":"Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome","volume":"4","author":"Stahl","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2021.02.011_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.V124800","article-title":"Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome","volume":"12","author":"Te Loo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0039-3400301","article-title":"Particulate Shiga toxin 2 in blood is associated to the development of hemolytic uremic syndrome in children","volume":"120","author":"Brigotti","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2021.02.011_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/toxins10020059","article-title":"An improved method for the sensitive detection of Shiga toxin 2 in human serum","volume":"10","author":"He","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib20","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/iai.62.8.3337-3347.1994","article-title":"Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in\u00a0vitro","volume":"62","author":"Bitzan","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajpath.2021.02.011_bib21","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1182\/blood.V97.10.3100","article-title":"Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome","volume":"97","author":"Karpman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.02.011_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V88.1.174.174","article-title":"Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release","volume":"88","author":"van Setten","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.02.011_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrneph.2017.98","article-title":"Extracellular vesicles in renal disease","volume":"13","author":"Karpman","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib24","doi-asserted-by":"crossref","first-page":"e1004619","DOI":"10.1371\/journal.ppat.1004619","article-title":"A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles","volume":"11","author":"Stahl","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ajpath.2021.02.011_bib25","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome","volume":"117","author":"Stahl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.02.011_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/toxins11040212","article-title":"Roles of Shiga toxins in immunopathology","volume":"11","author":"Lee","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib27","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib28","doi-asserted-by":"crossref","first-page":"e13000","DOI":"10.1111\/cmi.13000","article-title":"The structure of the Shiga toxin 2a A-subunit dictates the interactions of the toxin with blood components","volume":"21","author":"Brigotti","year":"2019","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib29","first-page":"41","article-title":"Ricin and Shiga toxins: effects on host cell signal transduction","volume":"357","author":"Jandhyala","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib30","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","article-title":"Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction","volume":"25","author":"Zoja","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib31","first-page":"137","article-title":"The induction of apoptosis by Shiga toxins and ricin","volume":"357","author":"Tesh","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1160\/TH08-05-0317","article-title":"Shiga toxins, glycosphingolipid diversity, and endothelial cell injury","volume":"101","author":"Muthing","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2021.02.011_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/toxins4030157","article-title":"The interactions of human neutrophils with Shiga toxins and related plant toxins: danger or safety?","volume":"4","author":"Brigotti","year":"2012","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib34","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0021-9258(19)85998-7","article-title":"Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils","volume":"255","author":"Macher","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2021.02.011_bib35","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","article-title":"Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils","volume":"191","author":"Brigotti","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/BJ20100455","article-title":"Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor","volume":"432","author":"Arfilli","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.ajpath.2021.02.011_bib37","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1086\/501472","article-title":"Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in\u00a0vivo: therapeutic implications for hemolytic-uremic syndrome","volume":"193","author":"Armstrong","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2021.02.011_bib38","doi-asserted-by":"crossref","first-page":"41576","DOI":"10.1074\/jbc.M107819200","article-title":"Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood","volume":"276","author":"Kimura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2021.02.011_bib39","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/IAI.71.10.6075-6078.2003","article-title":"Serum amyloid P component binding to Shiga toxin 2 requires both a subunit and B pentamer","volume":"71","author":"Marcato","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajpath.2021.02.011_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/jmm.0.47282-0","article-title":"Differential binding of Shiga toxin 2 to human and murine neutrophils","volume":"56","author":"Griener","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2249.2009.03854.x","article-title":"Soluble forms of toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells","volume":"156","author":"Zunt","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib42","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.micinf.2007.06.009","article-title":"Kinetics of toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis","volume":"9","author":"Jaresova","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ajpath.2021.02.011_bib43","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.4049\/jimmunol.165.12.6682","article-title":"Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling","volume":"165","author":"Iwami","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/toxins10090379","article-title":"Soluble toll-like receptor 4 impairs the interaction of Shiga toxin 2a with human serum amyloid P component","volume":"10","author":"Brigotti","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib45","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1038\/srep05237","article-title":"Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry","volume":"4","author":"Headland","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2021.02.011_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/labmed\/18.9.613","article-title":"Normal platelet and mean platelet volumes in pediatric patients","volume":"18","author":"Novak","year":"1987","journal-title":"Lab Med"},{"key":"10.1016\/j.ajpath.2021.02.011_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(79)80344-3","article-title":"Percentile curves for hemoglobin and red cell volume in infancy and childhood","volume":"94","author":"Dallman","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2021.02.011_bib49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3476(78)80429-6","article-title":"Developmental changes in red blood cell counts and indices of infants after exclusion of iron deficiency by laboratory criteria and continuous iron supplementation","volume":"92","author":"Saarinen","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2021.02.011_bib50","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1529\/biophysj.105.067496","article-title":"Force microscopy of nonadherent cells: a comparison of leukemia cell deformability","volume":"90","author":"Rosenbluth","year":"2006","journal-title":"Biophys J"},{"key":"10.1016\/j.ajpath.2021.02.011_bib51","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood.V81.10.2774.2774","article-title":"Volume and osmotic properties of human neutrophils","volume":"81","author":"Ting-Beall","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.02.011_bib52","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1152\/jappl.1990.69.5.1767","article-title":"Retention of leukocytes in capillaries: role of cell size and deformability","volume":"69","author":"Downey","year":"1990","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.ajpath.2021.02.011_bib53","series-title":"Rudolph's Pediatrics","author":"Dallman","year":"1977"},{"key":"10.1016\/j.ajpath.2021.02.011_bib54","series-title":"Pediatric Hematology-Oncology, a Treatise for the Clinician","author":"Lanzkowsky","year":"1980"},{"key":"10.1016\/j.ajpath.2021.02.011_bib55","series-title":"Blood Diseases of Infancy and Childhood","author":"Miller","year":"1984"},{"key":"10.1016\/j.ajpath.2021.02.011_bib56","series-title":"Hematology of Infancy and Childhood","author":"Nathan","year":"1987"},{"key":"10.1016\/j.ajpath.2021.02.011_bib57","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","article-title":"Verocytotoxin-producing Escherichia coli (VTEC)","volume":"140","author":"Karmali","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1570159X18666200220143001","article-title":"Therapeutic strategies to protect the central nervous system against Shiga toxin from enterohemorrhagic Escherichia coli","volume":"19","author":"Goldstein","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/INF.0b013e31822ea6cf","article-title":"An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values","volume":"31","author":"Lopez","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajpath.2021.02.011_bib60","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V95.11.3396","article-title":"Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome","volume":"95","author":"te Loo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2021.02.011_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cyto.b.20022","article-title":"Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome","volume":"61","author":"Tazzari","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.ajpath.2021.02.011_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1189\/jlb.0709475","article-title":"Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration","volume":"88","author":"Brigotti","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fcimb.2020.00212","article-title":"Shiga toxin-bearing microvesicles exert a cytotoxic effect on recipient cells only when the cells express the toxin receptor","volume":"10","author":"Johansson","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1574-695X.2010.00749.x","article-title":"Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells","volume":"61","author":"Torgersen","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib65","doi-asserted-by":"crossref","first-page":"e13249","DOI":"10.1111\/cmi.13249","article-title":"Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells","volume":"22","author":"Lee","year":"2020","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ajpath.2021.02.011_bib66","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1038\/s41598-018-29128-9","article-title":"Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice","volume":"8","author":"Watanabe-Takahashi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2021.02.011_bib67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.carbpol.2019.02.039","article-title":"Pectin-derived neoglycolipids: tools for differentiation of Shiga toxin subtypes and inhibitors of Shiga toxin-mediated cellular injury","volume":"212","author":"Pohlentz","year":"2019","journal-title":"Carbohydr Polym"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294402100078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294402100078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T04:32:10Z","timestamp":1762576330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294402100078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S000294402100078X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2021.02.011","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular Vesicles and Renal Endothelial Cells","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}